Background-The development of aortic valve stenosis is not only associated with calcification and extracellular matrix remodeling, but also with inflammation. The aim of this study was to determine the role of proinflammatory signaling through the leukotriene (LT) pathway in aortic stenosis. Methods and Results-After macroscopic dissection of surgically removed human aortic valves, RNA was extracted from 311 preparations derived from 68 patients to differentiate normal, thickened, and calcified areas from each cusp. Subsequently, quantitative polymerase chain reaction analysis was used to correlate gene expression patterns with preoperative echocardiographic parameters. The messenger RNA levels of the LT-forming enzyme 5-lipoxygenase increased 1.6-and 2.2-fold in thickened and calcified tissue, respectively, compared with normal areas of the same valves. In thickened tissues, messenger RNA levels for 5-lipoxygenase (rϭϪ0.35; Pϭ0.03), its activating protein (5-lipoxygenase activating protein; rϭϪ0.39; Pϭ0.02), and LTA 4 hydrolase (rϭϪ0.48; Pϭ0.01) correlated inversely with the velocity-time integral ratio. In addition, leukotriene A 4 hydrolase transcripts correlated inversely with aortic valve area, indexed for body surface area (rϭϪ0.52; Pϭ0.007). Immunohistochemical stainings revealed LT receptor expression on valvular myofibroblasts. In primary cultures of human myofibroblasts derived from stenotic aortic valves, Leukotriene C 4 (LTC 4 ) increased intracellular calcium, enhanced reactive oxygen species production, reduced the mitochondrial membrane potential, and led to morphological cell cytoplasm changes and calcification.
A lthough the primary risk factor for developing aortic stenosis is increasing age, 1 stenotic aortic valves share morphological characteristics with atherosclerotic lesions. For example, in the active disease process, lipid accumulation, 2 inflammatory infiltration, [3] [4] [5] neovascularization, 6, 7 extracellular matrix degradation, 8 -10 and extensive calcification 3,5,11 take place, which eventually cause the aortic valve to narrow. However, attempts to inhibit the hemodynamic progression of aortic stenosis using lipid-lowering drugs have not been successful. [12] [13] [14] The poor prognosis and increased mortality from aortic stenosis after the onset of symptoms in the absence of surgical valve replacement 15 provide a rationale for the pursuit of a medical treatment that impedes the hemodynamic progression of aortic valve disease.
Clinical Perspective on p 1325
Inflammatory infiltration of activated macrophages and T-cells, as well as cytokine release, has been described in human stenotic aortic valves. 11, 16, 17 Yet, the exact role of inflammation in the pathophysiology of aortic stenosis remains unknown. The aim of this study was to associate the local inflammatory response, exerted in aortic valves through the leukotriene (LT) pathway, with the clinical features of valvular function as determined echocardiographically. To this end, messenger RNA (mRNA) was extracted from human aortic valves derived from patients undergoing valve replacement surgery, and gene expression was measured by quantitative polymerase chain reaction (PCR). Through mac-roscopic dissection, normal, thickened, and calcified areas of each valvular cusp were differentiated and analyzed separately, allowing us to obtain a pattern of gene expression that represents the entire disease spectrum in each individual, from early signs to severe morphological changes and the eventual destruction of the aortic valve architecture.
LTs are arachidonate-derived lipid metabolites and potent inflammatory mediators that are formed by 5-lipoxygenase (5-LO) and its activating protein (5-LO activating protein [FLAP] ). LTs exert their effects by activating BLT 1 and BLT 2 receptors (BLT 2 R), the high-and low-affinity receptors for LTB 4 , respectively, 18 and cysteinal LT 1 (CysLT 1 ) and CysLT 2 receptors for Leukotriene C 4 (LTC 4 ), D 4 , and E 4 . These LT receptors are expressed on inflammatory cells, such as macrophages, lymphocytes, and granulocytes and on structural cells within the vascular and airway walls. 18 The function of LTs as inflammatory mediators was initially recognized through their robust effects as bronchoconstrictors; consequently, anti-LTs are used as treatments for asthma. 19 LTs also have effects on the cardiovascular system, and recent studies have demonstrated their involvement in atherosclerosis 20, 21 and restenosis after percutaneous angioplasty. 22, 23 Despite beneficial effects of anti-LTs in experimental atherosclerosis, no study has explored the role of LTs in aortic valve stenosis. Nevertheless, because some data on atherosclerosis can be extrapolated to aortic stenosis, we studied the effects of LTs in human aortic valves.
Methods

Patients
Human aortic valves for RNA extraction were obtained from 79 patients undergoing aortic valve replacement surgery. After the exclusion of 11 patients because of insufficient RNA quality, 68 patients were included in the subsequent analysis (48 men and 20 women, mean age 65.9Ϯ13.4 years). For cell and organ culture experiments, aortic valves from an additional 12 patients were used. The study was approved by the local ethics committee (Karolinska Institutet 2008/630-32), and all patients gave informed consent. Only patients with a normal preoperative coronary angiogram and no history of rheumatic heart disease were included in the study.
Echocardiography
All patients underwent 2-dimensional transthoracic Doppler echocardiography using a Philips IE33 system (Philips Medical Systems, Andover, MA). The left ventricular function and aortic root dimensions were measured according to the recommendations of the American Society of Echocardiography. 24 The severity of aortic valve stenosis was based on: (1) the ratio of the systolic velocitytime integral (VTI) in the left ventricle outflow tract to the VTI in the aortic valve; (2) the aortic valve area (AVA, cm 2 ) calculated using the continuity equation; (3) AVA indexed for body surface area (AVA/BSA, cm 2 /m 2 ); and (4) the mean transvalvular pressure gradient according to the current guidelines. 25, 26 The echocardiographic assessment of the aortic valve as bicuspid or tricuspid was confirmed intraoperatively.
On the basis of the echocardiographic assessment, the study population was categorized into 5 groups: (1) normal aortic valve (pathology of the aortic root and/or the ascending aorta without valve dysfunction in which valve-sparing surgery could not be performed according to perioperative surgical decision; nϭ4); (2) combined aortic vitium (ie, increased transvalvular pressure gradient without fulfilling the criteria for severe aortic stenosis and the presence of aortic valve regurgitation; nϭ7); (3) isolated aortic regurgitation (nϭ11); and finally, isolated severe aortic stenosis with either a (4) bicuspid (nϭ23) or (5) tricuspid (nϭ23) valve.
Sample Preparation and Macroscopic Dissection
Immediately after surgical removal, valves were immersed in RNA Later (Qiagen) and stored at 4°C until transport to the laboratory. Macroscopic dissection was performed in the RNA Later solution, dividing each valvular cusp into: (1) normal areas, defined as noncalcified, smooth, pliable, and opalescent; (2) thickened areas; and (3) calcified areas. From each class, 1 sample from each cusp was frozen at Ϫ80°C until RNA extraction and another part of the same cusp was used for histological analysis. The macroscopic definitions were verified by histology in a subset of preparations (nϭ89) using eosin and hematoxylin, Masson trichrome, and Alizarin red as indicated in online-only Data Supplement Figure I . Furthermore, the degree of calcification detected macroscopically in each cusp was in agreement with preoperative echocardiographic scoring of calcification.
RNA Extraction and Quality Assessment
Total RNA was isolated from 431 preparations from 79 patients, representing the various portions (normal, thickened, and calcified) from each aortic valve cusp, using the RNeasy Lipid Tissue Mini kit (Qiagen). RNA concentrations were measured spectrophotometrically at 260 nm (A260/280 nm, Agilent Technologies, Palo Alto, CA).
Then, the quality of the RNA was analyzed on a 2100 Bioanalyzer (Agilent, Palo Alto, CA) using RNA 6000 NANO chips to assess the RNA integrity number, as described. 27 To ensure sufficient RNA integrity, a regression was computed between the RNA integrity number and PCR results for each gene, establishing a cutoff RNA integrity number score of 3.1, corresponding to the value at which the association between them was lost.
Consequently, of the 79 valves that were collected for RNA analysis, 11 patients were excluded because if insufficient RNA quality, and the gene expression data for 311 preparations from 68 patients were used for further analysis. On average, 4 to 5 preparations were examined for each aortic valve. In subsequent analyses, a mean value of each tissue category (ie, normal, thickened, and calcified, respectively) was calculated for each individual.
TaqMan Real-Time PCR
First-strand complementary DNA was synthesized from 0.5 g RNA (Superscript II, Invitrogen, Carlsbad, CA) with random hexamers according to the manufacturer's instructions. Quantitative TaqMan PCR was performed on a 7900HT Fast Real-Time PCR system (Applied Biosystems) with primer/probe pairs that were obtained using Assay-on-Demand from Applied Biosystems (online-only Data Supplement Table I ); the reactions contained 5 L complementary DNA that was diluted to 1.5 ng/L and 5 L TaqMan Fast Universal PCR Master Mix (Applied Biosystems, Foster City, CA).
Immunohistochemistry
Transversal cryosections (10 m thick) were cut, oriented from the cusp base to the free edge, and fixed in acetone. Double immunofluorescent stainings were performed using polyclonal rabbit antihuman CysLT 1 receptor (Cayman Chemical Company) or 5-LO (Life Science Bioscience) and monoclonal mouse antihuman vimentin or CD68 (Dako) as primary antibodies. Isotype-specific either Texas Red or Alexa Fluor 488-conjugated secondary antibodies (Abcam) were used, and the nuclei were counterstained with 4Ј, 6-diamino-2phenylindol (DAPI, Vector). Images were viewed in Leica fluorescence microscope and captured with confocal microscope Leica TCS SP5.
Valve Conditioned Media
Conditioned media from stenotic valves was obtained as previously described. 28 In summary, 72 preparations of healthy, thickened, and calcified parts of stenotic aortic valves derived from 5 patients were incubated at 1 mL/g tissue (wet weight) for 24 hours at 37°C in serum-free Dulbecco's modified Eagle's medium supplemented with 100 IU/mL streptomycin, 50 IU/mL penicillin, and 2.5 g/mL Fungizone. Concentrations of CysLTs were measured using an enzyme immunoassay kit from Cayman Chemicals with a monoclonal antibody recognizing the total of all 3 CysLTs (LTC 4 , LTD 4 , and LTE 4 ), as previously described. 29 
Myofibroblast Isolation
Aortic valve samples from 7 patients were transported immediately in cell culture medium to the laboratory where the valves were cut into small cubes (1 to 2 mm in each dimension) using a scalpel and placed onto culture dishes to dry for Ϸ15 minutes under sterile conditions. Then, the valvular pieces were covered with Dulbecco's Modified Eagle's Medium supplemented with 10% heat-inactivated fetal bovine serum and antibiotics at 37°C and 5% CO 2 .
The culture medium was changed 3 times per week, and the outgrowth of valvular myofibroblasts was evaluated during 2 to 3 weeks. At this point, outgrown myofibroblasts were detached and reseeded for measurement of intracellular calcium concentrations, mitochondrial membrane potential, reactive oxygen species (ROS), calcified nodule formation, and transcriptional changes as described in the online-only Data Supplement (Methods).
Data Analysis
Clinical parameters and gene expression data are expressed as median and ranges. A nonparametric Mann-Whitney U test was used for comparisons between 2 groups, and a Kruskall-Wallis 1-Way ANOVA on ranks followed by all-pairwise Dunn post hoc testing for multiple comparisons. For myofibroblast experiments, data are expressed as meanϮSEM, and paired analysis was performed using either a Wilcoxon signed-rank test or a repeated measures ANOVA. Correlations between the quantitative gene expression data and echocardiographic parameters were established by Spearman correlation. PϽ0.05 was considered significant. A multiple stepwise linear regression was performed to evaluate the impact of the components of the 5-LO pathway on AVA/BSA. Analyses were performed using SigmaPlot version 11 (Systat Software Inc).
Results
Gene Expression Analysis
Patient characteristics are shown in Table 1 according to diagnosis group. Gene expression in the macroscopically normal area of the valve did not differ significantly between groups (online-only Data Supplement Table II ). Thus, the normal area, according to our macroscopic classification, 3 served as the control in subsequent analyses of mRNA levels in stenotic valves.
The inflammation-associated genes 5-LO, FLAP, LTA 4 H, CD68, CD8, and interleukin (IL) 1␤ increased gradually in thickened areas of the valves from stenotic valves compared with the control area of each individual valve ( Figure 1 ). Further increases in the transcription of 5-LO, FLAP, CD68, CD8, and IL-1␤ were observed in the calcified areas, but the differences in FLAP and LTA 4 H expression did not reach statistical significance. With regard to the 2 matrix metalloproteinases (MMPs) that we examined, MMP-9 levels increased in calcified tissues whereas MMP-2 remained constant between the 3 categories of valvular tissue (Figure 1 ). Conditioned media derived from different parts of stenotic valves exhibited gradually increased CysLT concentrations (healthy: 28.7Ϯ6.2 pg/mL; thickened: 40.9Ϯ2.9 pg/mL; calcified: 47.0Ϯ2.3 pg/mL; PϽ0.05).
Correlation of Gene Expression Data With Severity of Aortic Stenosis
Within the aortic stenosis group, the gene expression data obtained in the normal area of the valve exhibited no correlation with echocardiographic measures of stenosis severity, apart from the finding that MMP-9 correlated significantly with the mean transvalvular pressure gradient (onlineonly Data Supplement Table III ). In contrast, in the thickened areas, 5-LO, FLAP, and LTA 4 H correlated inversely with VTI ratio. In multiple linear stepwise regression, FLAP remained significantly correlated with VTI ratio (Pϭ0.025). In addition, the transcript levels for LTA 4 H, IL-1␤, and MMP-9 correlated inversely with AVA, indexed for BSA (Table 2) . Furthermore, mRNA levels for LTC 4 S correlated significantly with the mean transvalvular pressure gradient. There was a highly significant positive correlation between the expression levels for the components of the LT pathway (5-LO, FLAP, and LTA 4 H), as well as between these transcript and MMP-9 Values are medians and ranges unless otherwise stated. BMI indicates body mass index; AVA, aortic valve area; AVA/BSA, aortic valve area indexed for body surface area; VTI ratio, velocity-time integral ratio; Aorta Vmax, antegrade velocity across the narrowed aortic valve; P-mean, the mean transvalvular pressure; EF, ejection fraction; LVEDD, left ventricle end diastolic diameter. *PϽ0.05 compared with tricuspid. †PϽ0.05 compared with tricuspid and bicuspid; Kruskal-Wallis ANOVA on ranks followed by Dunn all-pairwise post hoc testing.
expression in thickened areas of stenotic aortic valves (data not shown). In addition, the expression levels of 5-LO were significantly correlated with those of CD68 (r ϭ0.409, Pϭ0.016, nϭ34). In the calcified areas, no significant correlations were found between the quantitative echocardiographic parameters and the gene expression data indicated in online-only Data Supplement Table IV ). However, the expression levels of several components of the 5-LO pathway in the calcified areas , T-lymphocyte marker; IL-1␤, interleukin 1␤; MMP-9, matrix metalloproteinase 9; MMP-2, matrix metalloproteinase 2; coeff, coefficient; AVA/BSA, aortic valve area indexed for body surface area; VTI ratio, velocity-time integral ratio; and P-mean, mean transvalvular pressure.
were significantly correlated with markers of osteogenic pathways, such as bone morphogenic proteins (BMPs) and runtrelated transcription factor 2 (Cbfa1/Runx2), as shown in Table 3 .
LT Receptor Expression in Aortic Valve Stenosis
On the basis of the upregulation of LT-synthesizing enzymes in stenotic valves and their correlation with the severity of aortic stenosis, we sought to measure the expression of LT receptors. BLT 1 receptor (BLT 1 R) expression levels differed significantly between control and thickened areas of stenotic valves whereas BLT 2 R receptor mRNA levels were unchanged between normal, thickened, and calcified areas in stenotic valves. CysLT 1 receptor was upregulated in thickened areas of stenotic valves compared with normal parts but downregulated in calcified areas of the same valves; these changes, however, were not statistically significant ( Figure 2 ). CysLT 2 receptor transcripts were downregulated in different stages of valvular disease without any significant changes.
Immunohistochemical Analysis
Double immunofluorescent staining of stenotic valves revealed that 5-LO colocalized with CD68-postive macrophages ( Figure 3A through 3C) and with vimentin-positive myofibroblasts 30 (Figure 3D through 3F) . Likewise, CysLT 1 receptor protein was detected in colocalization with CD68 ( Figure 3G through 3I) and vimentin ( Figure 3J through 3L) . The latter finding was, in addition, confirmed in primary myofibroblast cultures ( Figure 3N through 3O) in which the CysLT 1 receptor exhibited a perinuclear localization.
Comparison of Quantitative Gene Expression Data Between Tricuspid and Bicuspid Valves
Tricuspid and bicuspid valves did not differ with regard to the expression of any of the genes that we examined in normal or calcified tissue (data not shown). In contrast, the thickened areas of stenotic valves with tricuspid morphology expressed significantly higher levels of CD68, CD8, BLT 1 R, and BLT 2 R mRNA compared with thickened parts of bicuspid stenotic valves (Figure 4 ). The transcription of other components of the LT pathway and MMPs did not differ significantly between thickened parts from tricuspid and bicuspid valves (data not shown).
LTC 4 -Induced Effects in Human Valvular Myofibroblasts
Because the CysLT 1 R was expressed on valvular myofibroblasts (Figure 3) , the effects of one of its agonists, LTC 4 18 , was examined. Exposure of myofibroblasts to LTC 4 (1 nmol/L) for 15 to 30 minutes caused a significant rise in [Ca 2ϩ ], with the most pronounced increase detected in the nuclear and perinuclear region of the cell ( Figure 5A ). However, in the absence of extracellular Ca 2ϩ , no LTC 4induced increase in intracellular [Ca 2ϩ ] was detected ( Figure  5B ). Moreover, LTC 4 caused morphological changes to the myofibroblasts with an increase in the formation of vacuoles within the cytoplasm ( Figure 5D ). These changes were not evident when LTC 4 was applied in conjunction with the Ca 2ϩ -free Tyrode solution ( Figure 5E ). Because the latter changes in morphology are seen in cell death, 2 cellular signals that are involved in cell death were further examined, the increase in ROS and the dissipation of the mitochondrial membrane potential ⌬⌿ m . Interestingly, exposing myofibroblasts to LTC 4 increased mitochondrial ROS levels (110Ϯ26%, nϭ20, PϽ0.001), as measured by MitoSOX Red. Moreover, a time-dependent decrease in ⌬⌿ m was observed in the cells on exposure to LTC 4 (1 nmol/L; Figure 6 ).
Prolonged exposure of myofibroblast cultures to LTC 4 induced calcium nodule formation, as demonstrated by representative micrographs of Alizarin red stained cell cultures in online-only Data Supplement Figure IIA . Furthermore, after 24 hours of LTC 4 stimulation, myofibroblasts exhibited significantly increased mRNA levels of BMP-2 and BMP-6, whereas no significant differences were observed for Cbfa1/ Runx2 (online-only Data Supplement Figure IIB) . Finally, the levels of 5-LO expression were significantly higher in adherent monocytes compared with valvular myofibroblasts (expressed in 2 -⌬CT : 3.2ϫ10 -3 Ϯ1.1ϫ10 -3 (nϭ6) versus 2.9ϫ10 -5 Ϯ4.3ϫ10 -6 (nϭ4) for monocytes and valvular myofibroblasts, respectively (Pϭ0.010). Furthermore, after calcium-ionophore stimulation, monocyte supernatants contained significantly higher LT concentrations (1.6Ϯ0.08 ng/ mL; nϭ3) compared with supernatants derived from valvular myofibroblasts (0.31Ϯ0.01 ng/mL; nϭ3; PϽ0.001).
Discussion
Our results point to an important role of LTs in aortic valve stenosis. LT-producing enzymes and LT receptors were upregulated in thickened valve tissue. Further, 5-LO, FLAP, LTC 4 S and LTA 4 H expression levels correlated significantly with the severity of aortic valve stenosis. Also, LTC 4 induced nuclear calcium signaling, morphological changes, calcification, and mitochondrial ROS production in valvular myofibroblasts. Collectively, these data suggest an important role of the LT pathway in aortic stenosis; consequently, the inhibition of LT signaling may represent a therapeutic strategy for this disease.
In this study, the expression levels of several genes from various pathways that regulate aortic valve stenosis were compared between differentially affected areas of aortic valves, normal, leaflet thickening, and calcified aortic valve tissue. 3 Notably, the mRNA levels in morphologically normal areas of the valve did not differ significantly between diagnosis groups with different aortic valve conditions. The latter finding suggests that the division of aortic valves, based on macroscopic appearance, represents a model of the development of aortic stenosis over time.
In support of this model, the mRNA levels of markers for macrophages (CD68) and T-lymphocytes (CD8) were upregulated gradually as the valve progressed from healthy to thickened and calcified tissue, corroborating previous histological classifications of aortic valve stenosis and evidence of the steady infiltration of these inflammatory cells. 3 Similarly, transcripts of IL-1␤, MMP-9, and the LT-synthesizing enzyme 5-LO rose, correlating significantly with CD68 expression, supporting the hypothesis that activated macrophages are a major source of inflammatory mediators in stenotic aortic valves. 3 In addition, valvular myofibroblasts also exhibited 5-LO expression and LT synthesis, albeit at lower levels compared with leukocytes, suggesting structural valvular cells as an additional source of inflammation in aortic stenosis.
On the basis of this classification, 3 the early thickening of valve cusps before calcification represents an intermediate stage of aortic valve stenosis progression at which one can intervene and reverse the pathology. It is therefore interesting that our univariate correlation analysis in thickened areas of stenotic aortic valves revealed that, in addition to the already explored mediators of aortic stenosis, IL-1␤ 9 and MMP-9, 8, 9, 30 the mRNA levels for 5-LO, its activating protein FLAP, and the downstream enzymes LTC 4 S and LTA 4 H correlated significantly with severity of stenosis. When comparing thickened valve tissue between tricuspid and bicuspid stenotic aortic valves, only transcript levels for CD68, CD8, and the 2 BLT receptors increased significantly. The latter finding supports a dominant infiltration of leukocytes in tricuspid valve stenosis, whereas stenotic valve lesions with underlying bicuspid valve anatomy rather result from abnormally distributed mechanical stress. 31 Nevertheless, the lack of differences in terms of the 5-LO pathway expression between bi-and tricuspid aortic stenosis suggests that common inflammatory pathways may also exist within thickened early valvular lesions.
The MMP family of extracellular matrix-degrading enzymes also contributes to the pathophysiological changes that are associated with aortic stenosis. 32 Although the upregulation of MMP-9 in stenotic aortic valves 8, 33 was recapitulated in our study, MMP-2 expression was unaltered throughout disease progression. Yet, contradictory findings exist in the literature relative to the involvement of MMP-2 in the development of aortic valve stenosis. 8, 9, 34 Furthermore, the correlation between MMP-9 mRNA levels and 5-LO and FLAP expression that we observed corroborates evidence of LTB 4 -induced MMP secretion in restenosis, 23 abdominal aortic aneurysms, 35 and metastatic cancer, 36 hence linking the LT pathway to extracellular matrix degradation.
That the 5-LO pathway was upregulated in aortic valve stenosis led us to determine the effects of their downstream components. For example, LTA 4 H, expression of which correlated with stenosis severity, leads to the formation of LTB 4 , which signals through the BLT receptors. The increase in BLT 1 receptor expression in thickened areas of valvular tissue in the present study transduces a chemotactic response for macrophages, lymphocytes, and granulocytes. Beyond this enhanced leukocyte recruitment to stenotic valves and the stimulation of extracellular matrix degradation through the LTB 4 -BLT receptor pathway, also LTC 4 S expression was correlated with stenosis severity. The latter enzyme leads to the formation of LTC 4 , which has bronchoconstrictor properties, and induces contraction of human atherosclerotic coronary arteries. 37 LTC 4 -mediated contractility of smooth muscle cells has been demonstrated to be caused by influx of Ca 2ϩ via opening of plasma membrane Ca 2ϩ channels. 38 Valvular myofibroblasts are a mesenchymal cell type that share phenotypic similarities with vascular smooth muscle cells. Earlier investigations showed that vasoactive mediators, such as serotonin and angiotensin II, 39 increased cytoplasmic (Ca 2ϩ ) in myofibroblasts. In the present study, the LTC 4 -induced rise in cytoplasmic (Ca 2ϩ ) was most pronounced in the nuclear and perinuclear region of the cell, associated with mitochondrial permeability transition. Furthermore, in the presence of LTC 4 , myofibroblasts underwent time-dependent changes in cell morphology with overt formation of vacuoles in the cytoplasm. Taken together, these LTC 4 -induced processes may be associated with activation cell death pathways, 40 which have been implicated in valve pathology and calcification. 41 In addition, LTC 4 induced an increased ROS production, which has been associated with calcification in situ in human aortic valves 42 and also with osteoblast differentiation through induction of BMP-2. 43 In line with those findings, LTC 4 upregulated BMP-2 and BMP-6 mRNA in myofibroblasts in the present study, suggesting also a LT-induced stimulation of osteogenic pathways in aortic stenosis. The latter was further supported by the significant correlation between the components of the 5-LO and osteogenic pathways in calcified stenotic valves.
In summary, we provide evidence that LT-synthesizing enzymes are upregulated in thickened tissue from stenotic aortic valves and that their local expression levels correlate significantly with severity of stenosis. In addition, LTC 4 induced perinuclear calcium overload, increased ROS production and cytoplasmic vacuolization, calcified nodule formation, and induced osteogenic pathways in myofibroblasts. In conclusion, upregulation of the LT pathway in calcified aortic valve stenosis and the LTC 4 -induced effects on myofibroblast link inflammation and calcification, a finding that provide a first suggestion of therapeutic interventions with anti-LTs at the potentially modifiable, thickened aortic valve to prevent the development of aortic stenosis.
